Clinical trial
The Effect of mu Opioid Receptor Polymorphism on the Response to Alfentanil During Lithotripsy
NCT00226564 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of mu Opioid Receptor Polymorphism on the Response to Alfentanil During Lithotripsy
- Lead sponsor
- Hadassah Medical Organization
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 1997
- Completion date
- Not reported
- Enrollment
- 100
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.